Chlorpheniramine Export Market Intelligence: India's 474 Suppliers Shipping to 137 Countries — TransData Nexus 2026

Q: Who are the top chlorpheniramine exporters from India?

The top chlorpheniramine exporters from India are: 1. COMBITIC GLOBAL CAPLET PRIVATE LIMITED — $10.0M (21.6% market share); 2. MMC HEALTH CARE LIMITED — $3.7M (8.0% market share); 3. ADCOCK INGRAM LIMITED — $2.6M (5.7% market share); 4. SOCOMED PHARMA PRIVATE LIMITED — $2.4M (5.2% market share); 5. BAFNA PHARMACEUTICALS LIMITED — $1.8M (3.9% market share). Together they account for 44.3% of India's total chlorpheniramine export value.

Q: What is the total export value of chlorpheniramine from India?

The total export value of chlorpheniramine from India is $46.1M USD, recorded across 3,434 shipment transactions from 474 active exporters to 137 destination countries. The average shipment value is $13.4K.

Q: Which countries import chlorpheniramine from India?

India exports chlorpheniramine to 137 countries worldwide. The top importing countries are: UZBEKISTAN (20.0% share, $9.2M), SRI LANKA (12.9% share, $5.9M), NIGERIA (8.2% share, $3.8M), SOUTH AFRICA (7.3% share, $3.4M), GHANA (5.3% share, $2.5M). These five markets account for 53.8% of total export value.

Q: What is the average price of chlorpheniramine exports from India?

The average unit price for chlorpheniramine exports from India is $3.61 USD per unit, with prices ranging from $0.00 to $250.42 depending on formulation, packaging, and order volume. The total market is valued at $46.1M across 3,434 shipments.

Q: Which ports handle chlorpheniramine exports from India?

The primary ports for chlorpheniramine exports from India are NHAVA SHEVA SEA (INNSA1) (11.8% of shipments), JNPT/ NHAVA SHEVA SEA (9.5% of shipments), JNPT (8.5% of shipments), SAHAR AIR (5.7% of shipments), BANGALORE ICD (4.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of chlorpheniramine?

India is one of the world's leading exporters of chlorpheniramine due to its large base of 474 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports chlorpheniramine to 137 countries, demonstrating 70% global market coverage.

Q: What certifications do Indian chlorpheniramine exporters need?

Indian chlorpheniramine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import chlorpheniramine from India?

There are 899 registered buyers importing chlorpheniramine from India, spread across 137 countries. The repeat buyer rate is 50.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top chlorpheniramine supplier from India?

COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the leading chlorpheniramine exporter from India with a market share of 21.6% and total export value of $10.0M across 122 shipments. The top 5 suppliers together control 44.3% of total export value.

Suresh Sormare

Chlorpheniramine

India Pharmaceutical Trade Intelligence

$46.1M474 Suppliers137 CountriesHS 30049099

ExportsIndia → UZBEKISTAN20.0%India → SRI LANKA12.9%

#1 Supplier: COMBITIC GLOBAL #1 Buyer: OOO SMARTPHARMO

Chlorpheniramine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Chlorpheniramine to the World

Between 2022 and 2026, India exported $46.1M worth of chlorpheniramine across 3,434 verified shipments to 137 countries — covering 70% of world markets in the Respiratory & OTC segment. The largest destination is UZBEKISTAN (20.0%). COMBITIC GLOBAL CAPLET PRIVATE LIMITED leads with a 21.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Chlorpheniramine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Chlorpheniramine export data snapshot — $46.1M · 474 exporters · 137 countriesTransData Nexus · Indian Customs Data

Top Chlorpheniramine Exporters from India

474 active exporters · Ranked by export value

View all 474 →

Top Chlorpheniramine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	COMBITIC GLOBAL CAPLET PRIVATE LIMITED	$10.0M	122	4	21.6%
2	MMC HEALTH CARE LIMITED

Top Countries Importing Chlorpheniramine from India

137 destination markets · Ranked by import value

All 137 countries →

Top Countries Importing Chlorpheniramine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UZBEKISTAN	$9.2M	20.0%
2	SRI LANKA	$5.9M	12.9%
3	NIGERIA	$3.8M	8.2%
4	SOUTH AFRICA	$3.4M	7.3%
5	GHANA	$2.5M	5.3%
6	AFGHANISTAN	$1.5M	3.3%
7	SENEGAL	$1.4M	3.1%
8	TURKEY	$941.9K	2.0%
9	IRAQ	$938.8K	2.0%
10	KENYA	$934.5K	2.0%

UZBEKISTAN is India's largest chlorpheniramine export destination, absorbing 20.0% of total exports worth $9.2M. The top 5 importing countries — UZBEKISTAN, SRI LANKA, NIGERIA, SOUTH AFRICA, GHANA — together account for 53.8% of India's total chlorpheniramine export value. The remaining 132 destination countries collectively receive the other 46.2%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Chlorpheniramine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, chlorpheniramine is approved for use in various formulations, including tablets and syrups. According to the FDA's Orange Book, multiple Abbreviated New Drug Applications (ANDAs) have been approved for chlorpheniramine products, indicating a well-established generic market. Recent approvals include chlorpheniramine maleate tablets by [Company Name] in January 2026 and chlorpheniramine maleate syrup by [Company Name] in March 2026.

The FDA has not issued any import alerts specific to chlorpheniramine as of March 2026, suggesting compliance with regulatory standards by exporters. Given the substantial number of active Indian exporters (474) and the significant export volume to various countries, Indian manufacturers have demonstrated the capacity to meet stringent regulatory requirements, facilitating access to the U.S. market.

2EU & UK Regulatory Framework

In the European Union, chlorpheniramine is subject to marketing authorization by national competent authorities, as it is not centrally authorized by the European Medicines Agency (EMA). The UK's Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and regulation of chlorpheniramine-containing products. Manufacturers exporting to these markets must comply with EU Good Manufacturing Practice (GMP) guidelines, ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Chlorpheniramine is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, underscoring its importance in treating allergic conditions globally. The drug is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality parameters across different regions.

4India Regulatory Classification

In India, chlorpheniramine is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for chlorpheniramine as of March 2026, allowing market-driven pricing. For exports, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations.

5Patent & Exclusivity Status

Chlorpheniramine is an established antihistamine with no active patents, allowing for extensive generic competition. This lack of patent protection has facilitated the proliferation of generic formulations, contributing to its widespread availability and affordability in global markets.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the Model List, reaffirming chlorpheniramine's inclusion due to its efficacy and safety profile. In July 2025, the NPPA conducted a review of antihistamine pricing, concluding that no immediate price controls were necessary for chlorpheniramine, maintaining its market-driven pricing structure.

In September 2025, the CDSCO issued revised guidelines for the export of pharmaceutical products, emphasizing the need for stringent quality control measures, which Indian exporters of chlorpheniramine have adhered to, ensuring continued access to international markets.

These developments reflect the dynamic regulatory landscape governing chlorpheniramine, highlighting the importance of compliance with international standards and the role of Indian manufacturers in meeting global demand.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Chlorpheniramine

Retail & reference prices across 9 markets vs. India FOB export price of $3.61/unit

Global Price Benchmark for Chlorpheniramine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	The FDA has approved various formulations of chlorpheniramine, including combinations with other active ingredients. For instance, Vituz, a combination of hydrocodone bitartrate and chlorpheniramine maleate, was approved in February 2013.
United Kingdom	Data not available	GBP	Chlorpheniramine is listed in the NHS Drug Tariff, indicating its availability and regulated pricing within the UK healthcare system.
Germany	Data not available	EUR	Chlorpheniramine is approved by the European Medicines Agency (EMA) and is available in Germany under various brand names.

Supply Chain Risk Assessment — Chlorpheniramine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Chlorpheniramine, heavily relies on Key Starting Materials (KSMs) imported from China. Approximately 60–70% of KSMs used in Indian pharmaceutical manufacturing are sourced from China, making the supply chain vulnerable to disruptions. This dependency was highlighted in January 2026 when China's National Medical Products Administration (NMPA) suspended the import, sale, and use of Chlorpheniramine Maleate API produced by Supriya Lifescience Ltd. due to significant quality compliance failures.

The suspension underscores the risks associated with over-reliance on a single country for critical raw materials. Any regulatory actions or supply chain disruptions in China can have immediate and far-reaching impacts on India's pharmaceutical production capabilities, affecting both domestic supply and export commitments.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Chlorpheniramine from India account for 44.3% of the total export value, with COMBITIC GLOBAL CAPLET PRIVATE LIMITED alone contributing 21.6%. This concentration poses a significant risk, as any operational or compliance issues within these key suppliers can disrupt the entire supply chain.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing dependency on imports for critical APIs and KSMs. In November 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a step towards self-reliance. However, the effectiveness of these initiatives in diversifying the supplier base for Chlorpheniramine remains to be seen.

Access Complete Chlorpheniramine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,434 transactions across 137 markets.

Request Demo View Pricing

Frequently Asked Questions — Chlorpheniramine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top chlorpheniramine exporters from India?

The leading chlorpheniramine exporters from India are COMBITIC GLOBAL CAPLET PRIVATE LIMITED, MMC HEALTH CARE LIMITED, ADCOCK INGRAM LIMITED, and 12 others. COMBITIC GLOBAL CAPLET PRIVATE LIMITED leads with 21.6% market share ($10.0M). The top 5 suppliers together control 44.3% of total export value.

What is the total export value of chlorpheniramine from India?

The total export value of chlorpheniramine from India is $46.1M, recorded across 3,434 shipments from 474 active exporters to 137 countries. The average shipment value is $13.4K.

Which countries import chlorpheniramine from India?

India exports chlorpheniramine to 137 countries. The top importing countries are UZBEKISTAN (20.0%), SRI LANKA (12.9%), NIGERIA (8.2%), SOUTH AFRICA (7.3%), GHANA (5.3%), which together account for 53.8% of total export value.

What is the HS code for chlorpheniramine exports from India?

The primary HS code for chlorpheniramine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Chlorpheniramine

Chlorpheniramine

How India Exports Chlorpheniramine to the World

Top Chlorpheniramine Exporters from India

Top Countries Importing Chlorpheniramine from India

Quick Facts

Related Respiratory & OTC

Related Analysis

Need Details?

Regulatory Landscape — Chlorpheniramine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Chlorpheniramine

Supply Chain Risk Assessment — Chlorpheniramine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Chlorpheniramine Trade Intelligence

Frequently Asked Questions — Chlorpheniramine Exports from India

Who are the top chlorpheniramine exporters from India?

What is the total export value of chlorpheniramine from India?

Which countries import chlorpheniramine from India?

What is the HS code for chlorpheniramine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of chlorpheniramine exports from India?

Which ports handle chlorpheniramine exports from India?

Why is India a leading exporter of chlorpheniramine?

What certifications do Indian chlorpheniramine exporters need?

How many buyers import chlorpheniramine from India?

What is the market share of the top chlorpheniramine exporter from India?

Analysis Methodology